Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

High dose cyclophosphamide preferentially targets naïve T (CD45/CD4/RA+) cells in CIDP and MS patients.
Therapeutic class review, Neurological - multiple sclerosis dalfampridine (Ampyra(TM))
Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review.
Synthetic Biologics Announces Issuance of U.S. Patent Adding Another Layer of Protection for the Use of Oral Estriol Candidate, Trimesta™, for Multiple Sclerosis
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.
Reviewing the Unmet Needs of Patients with Multiple Sclerosis.
Signal Transduction in the Blood-Brain Barriers
Efficacy and safety study of RPC1063 in relapsing multiple sclerosis patients
Uhthoff's phenomena in MS-clinical features and pathophysiology.
Current and future disease-modifying therapies in multiple sclerosis.
EFNS 2012
Immunology 2013
Receptos Initiates SUNBEAM Phase 3 Trial of RPC1063 in Relapsing Multiple Sclerosis
Predictive value of early brain atrophy on response in patients treated with interferon β.
Fourth PML Case With Tecfidera in MS Calls for Vigilance
Enzon presents pre-clinical data on controlled release of PEGylated interferon-beta-1b and PEGylated anti-TNF-a antibody fragment at the Controlled Release Society annual meeting
Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration.
Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.
Cortical demyelination and diffuse white matter injury in multiple sclerosis.
Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.
The potential teratogenic effects of interferon beta-1a (IFNβ-1a) and interferon beta-1b (IFNβ-1b) on in vitro embryonic development.
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.
Impact of MS during the critical window of brain development.
Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1.
Monoclonal antibodies conjugated with superparamagnetic iron oxide particles allow magnetic resonance imaging detection of lymphocytes in the mouse brain.

Pages